|
|
Volumn 29, Issue 10, 2011, Pages 859-
|
|
Drug pipeline: Q311
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFLIBERCEPT;
ALEMTUZUMAB;
ANTIDIABETIC AGENT;
ANTISENSE OLIGONUCLEOTIDE;
BRENTUXIMAB VEDOTIN;
CRIZOTINIB;
DAPAGLIFLOZIN;
ETEPLIRSEN;
EYLEA;
HEPATITIS B VACCINE;
ICATIBANT;
INFLUENZA VACCINE;
LAQUINIMOD;
LEBRIKIZUMAB;
MONOCLONAL ANTIBODY;
NICOTINE VACCINE;
PASIREOTIDE;
PEGAPTANIB;
PEPTIDE;
PERTUZUMAB;
POLYCLONAL ANTIBODY;
RECOMBINANT PARATHYROID HORMONE;
RUXOLITINIB;
STEROID;
TALIGLUCERASE ALFA;
UNCLASSIFIED DRUG;
VEMURAFENIB;
XALKORI;
ANGINA PECTORIS;
ANGIONEUROTIC EDEMA;
ASTHMA;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CORONARY ARTERY DISEASE;
CUSHING DISEASE;
DIABETIC MACULAR EDEMA;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
DUCHENNE MUSCULAR DYSTROPHY;
FOOD AND DRUG ADMINISTRATION;
GAUCHER DISEASE;
HEPATITIS B;
HODGKIN DISEASE;
HUMAN;
HYPOPARATHYROIDISM;
INFLUENZA;
INFLUENZA VACCINATION;
LARGE CELL LYMPHOMA;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
MELANOMA;
MULTIPLE SCLEROSIS;
MYELOPROLIFERATIVE DISORDER;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NOTE;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RETINA MACULA AGE RELATED DEGENERATION;
SMOKING CESSATION;
TOBACCO DEPENDENCE;
TREATMENT OUTCOME;
UNITED STATES;
VIRUS LIKE AGENT;
CLINICAL TRIALS AS TOPIC;
DECISION MAKING;
DRUG APPROVAL;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 80054735099
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.1999 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
